Direct-to-consumer genetic testing may create unrealistic expectations for patients and a conundrum for physicians who largely feel unprepared to discuss test results, says a recent study. Using data from the Impact of Personal Genomics Study, a large, longitudinal study of actual users of 23andMe and Pathway Genomics DTC genetic tests, researchers described the characteristics and […]
